Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 1:37 PM
Ignite Modification Date:
2025-12-25 @ 12:36 PM
NCT ID:
NCT00859495
Group ID:
EG000
Title:
Multimodal Lung Sparing Regimen
Description:
Intrapleural chemotherapy plus systemic chemotherapy:
Thoracoscopy to implant two intrapleural catheters followed by intrapleural chemotherapy with doxorubicin and cisplatin (weeks 1, 2, 4, 5, 7, and 8). Systemic chemotherapy treatments with cisplatin and pemetrexed during weeks 3, 6, and 9. Intrapleural radiotherapy with P-32 will be given 3 weeks after last dose of chemotherapy and 11 to 12 weeks after initial thoracoscopy.
Doxorubicin: A medication used in cancer chemotherapy, derived by chemical semisynthesis from a bacterial species.
Cisplatin: Platinum-based antineoplastic
Pemetrexed: Folate Analog Metabolic Inhibitor
Radiotherapy: Standard procedure given 3 weeks after last dose of chemotherapy
Deaths Number Affected:
0
Deaths Number At Risk:
None
Serious Number Affected:
0
Serious Number At Risk:
9
Other Number Affected:
0
Other Number At Risk:
9
Study:
NCT00859495
Results Section:
NCT00859495
Adverse Events Module:
NCT00859495